Packaged food stocks lag drug stocks amid GLP-1 drug fears, but recovery signs emerge in 2026.
Packaged food stocks have significantly underperformed pharmaceutical stocks over the past year, driven largely by concerns over GLP-1 weight-loss drugs impacting food demand. While Eli Lilly's stock soared 74%, many food companies like Campbell's an...
